Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Andriol
2. Nebido
3. Pantestone
4. Restandol
5. Testosterone Undecylate
6. Undestor
1. 5949-44-0
2. Andriol
3. Testosterone Undecylate
4. Nebido
5. Testosterone (undecanoate)
6. Aveed
7. Org 538
8. Testosterone Undeconate
9. Jatenzo
10. Testosterone Undecanoate [usan]
11. Testosterone, Undecanoate (ester)
12. Undestor
13. H16a5vct9c
14. Org-538
15. Testosterone 17.beta.-undecylate
16. Tsx-011
17. [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] Undecanoate
18. Mk-3033
19. Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17b)-
20. Pantestone
21. Restandol
22. T Undecanoate
23. Testosterone Undecanoate (usan)
24. Rextoro
25. Nebido-r
26. Reandron 1000
27. Einecs 227-712-6
28. Unii-h16a5vct9c
29. Brn 3176734
30. 17beta-hydroxyandrost-4-en-3-one Undecanoate
31. Andriol (tn)
32. Aveed (tn)
33. 5-alpha-androstan-3-one, 17-beta-hydroxy-, Undecanoate
34. Bay 86-5037
35. 3-oxoandrost-4-en-17beta-yl Undecanoate
36. Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta)-
37. Testosterone, Undecanoate
38. 4-08-00-00981 (beilstein Handbook Reference)
39. Schembl147620
40. Chembl2107067
41. Clr-610
42. Dtxsid90863661
43. Chebi:135741
44. Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17beta)-
45. (8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl Undecanoate
46. Bcp11921
47. Hy-b0626
48. Zinc8214690
49. Mfcd00468114
50. Testosterone Undecanoate [mi]
51. Akos016010255
52. Cs-4342
53. Db13946
54. Gs-6598
55. Testosterone Undecylate [mart.]
56. 17beta-undecanoyloxy-4-androsten-3-one
57. Testosterone Undecanoate [vandf]
58. Ncgc00484056-01
59. Testosterone Undecanoate [who-dd]
60. Testosterone Undecanoate [orange Book]
61. D06087
62. (17beta)-3-oxoandrost-4-en-17-yl Undecanoate
63. (17-beta)-3-oxoandrost-4-en-17-yl Undecanoate
64. 949t440
65. 3-oxoandrost-4-en-17.beta.-yl Undecanoate
66. W-105318
67. Q15410178
68. 17.beta.-hydroxyandrost-4-en-3-one Undecanoate
69. (17.beta.)-17-hydroxyandrost-4-en-3-one Undecanoate
70. 5-.alpha.-androstan-3-one, 17-.beta.-hydroxy-, Undecanoate
71. Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17.beta.)-
72. .delta.(sup 4)-androsten-17.beta.-ol-3-one Undecanoate
73. Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-(17.beta.)
74. (1s,2r,10r,11s,14s,15s)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadec-6-en-14-yl Undecanoate
75. (1s,2r,10r,11s,14s,15s)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl Undecanoate
Molecular Weight | 456.7 g/mol |
---|---|
Molecular Formula | C30H48O3 |
XLogP3 | 8.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 11 |
Exact Mass | 456.36034539 g/mol |
Monoisotopic Mass | 456.36034539 g/mol |
Topological Polar Surface Area | 43.4 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 739 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Aveed |
PubMed Health | Testosterone (Injection) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Aveed (testosterone undecanoate) injection contains testosterone undecanoate (17-undecanoyloxy-4-androsten-3-one) which is an ester of the androgen, testosterone. Testosterone is formed by cleavage of the ester side chain of testosterone undecanoat... |
Active Ingredient | Testosterone undecanoate |
Dosage Form | Injectable |
Route | Intramuscular |
Strength | 750mg/3ml (250mg/ml) |
Market Status | Prescription |
Company | Endo Pharms |
2 of 2 | |
---|---|
Drug Name | Aveed |
PubMed Health | Testosterone (Injection) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Aveed (testosterone undecanoate) injection contains testosterone undecanoate (17-undecanoyloxy-4-androsten-3-one) which is an ester of the androgen, testosterone. Testosterone is formed by cleavage of the ester side chain of testosterone undecanoat... |
Active Ingredient | Testosterone undecanoate |
Dosage Form | Injectable |
Route | Intramuscular |
Strength | 750mg/3ml (250mg/ml) |
Market Status | Prescription |
Company | Endo Pharms |
Testosterone undecanoate is indicated for replacement therapy in adult males with conditions that are linked with an absence or deficiency in endogenous testosterone production.
FDA Label
Testosterone plays a key role in male sexual differentiation and is involved in regulation of hematopoiesis, body composition, and bone metabolism. As a result, testosterone replacement therapy in males with hypogonadism can result in improved sexual function, increased lean body mass, bone density, erythropoiesis, prostate size, and changes in lipid profiles.
Androgens
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)
Absorption
The absorption of testosterone undecanoate varies based on the formulation. The intramuscular formulation of testosterone esters is suspended in oil and is absorbed from the lipid phase. Testosterone is released when tissue esterases cleave the undecanoic acid side chain. The oral formulation of testosterone undecanoate is also formulated as a prodrug, is best absorbed with food and ideal absorption occurs when taken with a meal containing at least 30 g of fat.
Route of Elimination
The majority (~90%) of an intramuscularly administered dose of testosterone is conjugated and eliminated in the urine. Approximately 6% of the dose is eliminated primarily unconjugated in the feces.
The side chain of testosterone undecanoate is cleaved by non specific esterases when it enters circulation and the undecanoic acid side chain is metabolized by the beta-oxidation pathway. The resulting Testosterone molecule is then metabolized to dihydrotestosterone (DHT) by the enzyme 5-alpha reductase. DHT is reduced by 3-alpha-hydroxysteroid dehydrogenase (major) and 3-beta-hydroxysteroid dehydrogenase prior to being glucuronidated and cleared by the kidneys. It should be noted that testosterone is metabolized to several other 17-keto steroids in the body.
Based on one source, Testosterone undecanoate in castor oil (for intramuscular injection) has a half life of 33.9 days, allowing it to maintain serum levels in the normal range for over 6 weeks. It should be noted that the half life of testosterone reported in the literature is inconsistent.
Testosterone is produced by Leydig cells and exerts it's effects by binding to androgen receptors throughout the body. Testosterone affects the voice, genitalia, mood, and influences muscle growth and protein expression. Accordingly, males with low levels of testosterone often experience decreased libido, fatigue, mood changes and dysphoria. Exogenous sources of testosterone are designed to mimic the effects of endogenous testosterone.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Testosterone Undecanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Testosterone Undecanoate, including repackagers and relabelers. The FDA regulates Testosterone Undecanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Testosterone Undecanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Testosterone Undecanoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Testosterone Undecanoate supplier is an individual or a company that provides Testosterone Undecanoate active pharmaceutical ingredient (API) or Testosterone Undecanoate finished formulations upon request. The Testosterone Undecanoate suppliers may include Testosterone Undecanoate API manufacturers, exporters, distributors and traders.
click here to find a list of Testosterone Undecanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Testosterone Undecanoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Testosterone Undecanoate active pharmaceutical ingredient (API) in detail. Different forms of Testosterone Undecanoate DMFs exist exist since differing nations have different regulations, such as Testosterone Undecanoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Testosterone Undecanoate DMF submitted to regulatory agencies in the US is known as a USDMF. Testosterone Undecanoate USDMF includes data on Testosterone Undecanoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Testosterone Undecanoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Testosterone Undecanoate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Testosterone Undecanoate Drug Master File in Korea (Testosterone Undecanoate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Testosterone Undecanoate. The MFDS reviews the Testosterone Undecanoate KDMF as part of the drug registration process and uses the information provided in the Testosterone Undecanoate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Testosterone Undecanoate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Testosterone Undecanoate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Testosterone Undecanoate suppliers with KDMF on PharmaCompass.
A Testosterone Undecanoate written confirmation (Testosterone Undecanoate WC) is an official document issued by a regulatory agency to a Testosterone Undecanoate manufacturer, verifying that the manufacturing facility of a Testosterone Undecanoate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Testosterone Undecanoate APIs or Testosterone Undecanoate finished pharmaceutical products to another nation, regulatory agencies frequently require a Testosterone Undecanoate WC (written confirmation) as part of the regulatory process.
click here to find a list of Testosterone Undecanoate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Testosterone Undecanoate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Testosterone Undecanoate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Testosterone Undecanoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Testosterone Undecanoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Testosterone Undecanoate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Testosterone Undecanoate suppliers with NDC on PharmaCompass.
Testosterone Undecanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Testosterone Undecanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Testosterone Undecanoate GMP manufacturer or Testosterone Undecanoate GMP API supplier for your needs.
A Testosterone Undecanoate CoA (Certificate of Analysis) is a formal document that attests to Testosterone Undecanoate's compliance with Testosterone Undecanoate specifications and serves as a tool for batch-level quality control.
Testosterone Undecanoate CoA mostly includes findings from lab analyses of a specific batch. For each Testosterone Undecanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Testosterone Undecanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Testosterone Undecanoate EP), Testosterone Undecanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Testosterone Undecanoate USP).
LOOKING FOR A SUPPLIER?